GlassScriptPhysician profile
David Q Santos
NPI 1386674802
$809.48
in general payments reported to CMS, 2019-2025
8 companies · $47.56 in 2025
The $47.56 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $41.05 · 2022: $29.66 · 2023: $369 · 2024: $183 · 2025: $47.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $324.97 | 2023-2024 | Dysport |
| Medtronic, INC. | $168.76 | 2023 | Nim Vital, Nim-Response |
| Medtronic USA, INC. | $138.91 | 2019 | |
| Alk-Abello, INC | $78.82 | 2022-2025 | Grastek, Ragwitek, Odactra |
| Regeneron Healthcare Solutions, INC. | $31.97 | 2024 | Dupixent |
| Mentor Worldwide LLC | $25.00 | 2025 | Mentor Siltex Round Spectrum |
| Stryker Corporation | $21.98 | 2020 | |
| Intersect Ent, INC. | $19.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.